↓ Skip to main content

Bispecific Antibodies in Multiple Myeloma: Present and Future

Overview of attention for article published in Blood Cancer Discovery, August 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#44 of 140)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news
1 news outlet
twitter
18 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bispecific Antibodies in Multiple Myeloma: Present and Future
Published in
Blood Cancer Discovery, August 2021
DOI 10.1158/2643-3230.bcd-21-0028
Pubmed ID
Authors

Guido Lancman, Dahniel L. Sastow, Hearn J. Cho, Sundar Jagannath, Deepu Madduri, Samir S. Parekh, Shambavi Richard, Joshua Richter, Larysa Sanchez, Ajai Chari

Twitter Demographics

The data shown below were collected from the profiles of 18 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 28%
Unspecified 4 14%
Student > Doctoral Student 2 7%
Other 1 3%
Student > Master 1 3%
Other 1 3%
Unknown 12 41%
Readers by discipline Count As %
Medicine and Dentistry 5 17%
Unspecified 4 14%
Biochemistry, Genetics and Molecular Biology 4 14%
Agricultural and Biological Sciences 2 7%
Immunology and Microbiology 1 3%
Other 1 3%
Unknown 12 41%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2022.
All research outputs
#1,374,707
of 21,691,316 outputs
Outputs from Blood Cancer Discovery
#44
of 140 outputs
Outputs of similar age
#31,778
of 340,345 outputs
Outputs of similar age from Blood Cancer Discovery
#4
of 11 outputs
Altmetric has tracked 21,691,316 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.